Late effects of langerhans cell histiocytosis and its association with malignancy

Riccardo Haupt, Vasanta Nanduri, R. Maarten Egeler

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Langerhans cell histiocytosis (LCH), although considered a benign and treatable condition, can result in sequelae in the various tissues involved. Some of the problems, such as diabetes insipidus (DI), can arise at the time of diagnosis of LCH or even before. It has therefore been suggested that the term 'permanent consequences' might be better than the term 'late effects' when describing these disabilities (Gadner et al., 1994). It was recognized decades ago that up to half the survivors of LCH may have residual disabilities which impact on the quality of survival (Komp et al., 1980; Komp, 1980). There have since been reports from single institutions and from co-operative national groups describing long-term complications in LCH patients (Sims, 1977; Ceci et al., 1993; Gadner et al., 1994; French LCH Study Group, 1996; Willis et al., 1996; Haupt et al., 2004). However, there are considerable differences in the reported incidence and prevalence of sequelae, ranging from 20% to 70%, in the various studies. This discrepancy may be due to several different factors including the study size, selection of patient cohorts, treatments used, definitions for diagnosis of sequelae, referral bias to institutions and methods used for follow-up assessment (telephone interviews, questionnaire-based studies and clinical examination) (Table 14.1). Most of the published literature on permanent consequences are follow-up studies in subjects who had LCH during childhood.

Original languageEnglish
Title of host publicationHistiocytic Disorders of Children and Adults
PublisherCambridge University Press
Pages272-292
Number of pages21
ISBN (Print)9780511545252, 0521839297, 9780521839297
DOIs
Publication statusPublished - Jan 1 2005

Fingerprint

Langerhans Cell Histiocytosis
Neoplasms
Examination Tables
Diabetes Insipidus
Patient Selection
Survivors
Referral and Consultation
Interviews
Survival
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Haupt, R., Nanduri, V., & Egeler, R. M. (2005). Late effects of langerhans cell histiocytosis and its association with malignancy. In Histiocytic Disorders of Children and Adults (pp. 272-292). Cambridge University Press. https://doi.org/10.1017/CBO9780511545252.015

Late effects of langerhans cell histiocytosis and its association with malignancy. / Haupt, Riccardo; Nanduri, Vasanta; Egeler, R. Maarten.

Histiocytic Disorders of Children and Adults. Cambridge University Press, 2005. p. 272-292.

Research output: Chapter in Book/Report/Conference proceedingChapter

Haupt, R, Nanduri, V & Egeler, RM 2005, Late effects of langerhans cell histiocytosis and its association with malignancy. in Histiocytic Disorders of Children and Adults. Cambridge University Press, pp. 272-292. https://doi.org/10.1017/CBO9780511545252.015
Haupt R, Nanduri V, Egeler RM. Late effects of langerhans cell histiocytosis and its association with malignancy. In Histiocytic Disorders of Children and Adults. Cambridge University Press. 2005. p. 272-292 https://doi.org/10.1017/CBO9780511545252.015
Haupt, Riccardo ; Nanduri, Vasanta ; Egeler, R. Maarten. / Late effects of langerhans cell histiocytosis and its association with malignancy. Histiocytic Disorders of Children and Adults. Cambridge University Press, 2005. pp. 272-292
@inbook{e9d25cb169c849ae8d3c73259ad6e79d,
title = "Late effects of langerhans cell histiocytosis and its association with malignancy",
abstract = "Langerhans cell histiocytosis (LCH), although considered a benign and treatable condition, can result in sequelae in the various tissues involved. Some of the problems, such as diabetes insipidus (DI), can arise at the time of diagnosis of LCH or even before. It has therefore been suggested that the term 'permanent consequences' might be better than the term 'late effects' when describing these disabilities (Gadner et al., 1994). It was recognized decades ago that up to half the survivors of LCH may have residual disabilities which impact on the quality of survival (Komp et al., 1980; Komp, 1980). There have since been reports from single institutions and from co-operative national groups describing long-term complications in LCH patients (Sims, 1977; Ceci et al., 1993; Gadner et al., 1994; French LCH Study Group, 1996; Willis et al., 1996; Haupt et al., 2004). However, there are considerable differences in the reported incidence and prevalence of sequelae, ranging from 20{\%} to 70{\%}, in the various studies. This discrepancy may be due to several different factors including the study size, selection of patient cohorts, treatments used, definitions for diagnosis of sequelae, referral bias to institutions and methods used for follow-up assessment (telephone interviews, questionnaire-based studies and clinical examination) (Table 14.1). Most of the published literature on permanent consequences are follow-up studies in subjects who had LCH during childhood.",
author = "Riccardo Haupt and Vasanta Nanduri and Egeler, {R. Maarten}",
year = "2005",
month = "1",
day = "1",
doi = "10.1017/CBO9780511545252.015",
language = "English",
isbn = "9780511545252",
pages = "272--292",
booktitle = "Histiocytic Disorders of Children and Adults",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Late effects of langerhans cell histiocytosis and its association with malignancy

AU - Haupt, Riccardo

AU - Nanduri, Vasanta

AU - Egeler, R. Maarten

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Langerhans cell histiocytosis (LCH), although considered a benign and treatable condition, can result in sequelae in the various tissues involved. Some of the problems, such as diabetes insipidus (DI), can arise at the time of diagnosis of LCH or even before. It has therefore been suggested that the term 'permanent consequences' might be better than the term 'late effects' when describing these disabilities (Gadner et al., 1994). It was recognized decades ago that up to half the survivors of LCH may have residual disabilities which impact on the quality of survival (Komp et al., 1980; Komp, 1980). There have since been reports from single institutions and from co-operative national groups describing long-term complications in LCH patients (Sims, 1977; Ceci et al., 1993; Gadner et al., 1994; French LCH Study Group, 1996; Willis et al., 1996; Haupt et al., 2004). However, there are considerable differences in the reported incidence and prevalence of sequelae, ranging from 20% to 70%, in the various studies. This discrepancy may be due to several different factors including the study size, selection of patient cohorts, treatments used, definitions for diagnosis of sequelae, referral bias to institutions and methods used for follow-up assessment (telephone interviews, questionnaire-based studies and clinical examination) (Table 14.1). Most of the published literature on permanent consequences are follow-up studies in subjects who had LCH during childhood.

AB - Langerhans cell histiocytosis (LCH), although considered a benign and treatable condition, can result in sequelae in the various tissues involved. Some of the problems, such as diabetes insipidus (DI), can arise at the time of diagnosis of LCH or even before. It has therefore been suggested that the term 'permanent consequences' might be better than the term 'late effects' when describing these disabilities (Gadner et al., 1994). It was recognized decades ago that up to half the survivors of LCH may have residual disabilities which impact on the quality of survival (Komp et al., 1980; Komp, 1980). There have since been reports from single institutions and from co-operative national groups describing long-term complications in LCH patients (Sims, 1977; Ceci et al., 1993; Gadner et al., 1994; French LCH Study Group, 1996; Willis et al., 1996; Haupt et al., 2004). However, there are considerable differences in the reported incidence and prevalence of sequelae, ranging from 20% to 70%, in the various studies. This discrepancy may be due to several different factors including the study size, selection of patient cohorts, treatments used, definitions for diagnosis of sequelae, referral bias to institutions and methods used for follow-up assessment (telephone interviews, questionnaire-based studies and clinical examination) (Table 14.1). Most of the published literature on permanent consequences are follow-up studies in subjects who had LCH during childhood.

UR - http://www.scopus.com/inward/record.url?scp=84928284741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928284741&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511545252.015

DO - 10.1017/CBO9780511545252.015

M3 - Chapter

AN - SCOPUS:84928284741

SN - 9780511545252

SN - 0521839297

SN - 9780521839297

SP - 272

EP - 292

BT - Histiocytic Disorders of Children and Adults

PB - Cambridge University Press

ER -